beta glucan/infarction

Nuoroda įrašoma į mainų sritį

Pasirinkite rūšiavimo tipą

5 rezultatus

Oral β-glucan reduces infarction size and improves regional contractile function in a porcine ischaemia/reperfusion model.

Straipsnius versti gali tik registruoti vartotojai

Prisijungti Registracija

OBJECTIVE We previously reported a cardioprotective effect of oral β-glucan in patients who underwent coronary artery bypass grafting. The present study was conducted to determine whether oral β-glucan could reduce myocardial infarction size and whether these changes would be reflected by better

Pretreatment with β-glucan attenuates isoprenaline-induced myocardial injury in rats.

Straipsnius versti gali tik registruoti vartotojai

Prisijungti Registracija

What is the central question of this study? The study was designed to assess whether pretreatment with β-glucan could exert any protective action against isoprenaline-induced myocardial injury in rats. What is the main finding and its importance? β-Glucan pretreatment could reduce

Protective effects of betaglucin on myocardial tissue during myocardial infarction in rats and dogs.

Straipsnius versti gali tik registruoti vartotojai

Prisijungti Registracija

OBJECTIVE To test the protective effects of betaglucin, a novel beta-glucan, on models of myocardial infarction (MI) in rats and dogs. METHODS The left anterior descending (LAD) coronary artery occlusion model was used to induce an MI in rats and dogs. Three doses of betaglucin (10, 30 and 100

Cost-effectiveness of Maintaining Daily Intake of Oat β-Glucan for Coronary Heart Disease Primary Prevention.

Straipsnius versti gali tik registruoti vartotojai

Prisijungti Registracija

OBJECTIVE Oat β-glucan reduces cholesterol levels and thus reduces the risk for coronary heart disease (CHD). However, its economic impact has not been well studied. We examined the economic impact of daily intake of ≥3 g of oat β-glucan in primary prevention of CHD in patients receiving statins or

Pharmacologic management of isolated low high-density lipoprotein syndrome.

Straipsnius versti gali tik registruoti vartotojai

Prisijungti Registracija

High-density lipoprotein (HDL) cholesterol is a heterogeneous group of lipoproteins exhibiting a variety of properties like prostacyclin production stimulation, decrease in platelet aggregation, endothelial cell apoptosis inhibition, and low-density lipoprotein oxidation blockade. Epidemiologic

Prisijunkite prie mūsų
„Facebook“ puslapio

Herbal & Natural Medicine

Išsamiausia vaistinių žolelių duomenų bazė, paremta mokslu

Dirba 55 kalbomis
Žolelių gydymas, paremtas mokslu
Vaistažolių atpažinimas pagal vaizdą
Interaktyvus GPS žemėlapis - pažymėkite vaistažoles vietoje (netrukus)
Skaitykite mokslines publikacijas, susijusias su jūsų paieška
Ieškokite vaistinių žolelių pagal jų poveikį
Susitvarkykite savo interesus ir sekite naujienas, klinikinius tyrimus ir patentus

Įveskite simptomą ar ligą ir perskaitykite apie žoleles, kurios gali padėti, įveskite žolę ir pamatykite ligas bei simptomus, nuo kurių ji naudojama.
* Visa informacija pagrįsta paskelbtais moksliniais tyrimais